SG11201608761PA - Methods of cellular reprogramming - Google Patents

Methods of cellular reprogramming

Info

Publication number
SG11201608761PA
SG11201608761PA SG11201608761PA SG11201608761PA SG11201608761PA SG 11201608761P A SG11201608761P A SG 11201608761PA SG 11201608761P A SG11201608761P A SG 11201608761PA SG 11201608761P A SG11201608761P A SG 11201608761PA SG 11201608761P A SG11201608761P A SG 11201608761PA
Authority
SG
Singapore
Prior art keywords
methods
cellular reprogramming
reprogramming
cellular
Prior art date
Application number
SG11201608761PA
Inventor
Andrew Chwee Aun Wan
Jia Kai Lim
Vivian Yujing Lim
Nina Ma
Siti Thaharah Mohamed
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG11201608761PA priority Critical patent/SG11201608761PA/en
Publication of SG11201608761PA publication Critical patent/SG11201608761PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/585—Integrins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/30—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cancer cells, e.g. reversion of tumour cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201608761PA 2014-04-23 2015-04-23 Methods of cellular reprogramming SG11201608761PA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG11201608761PA SG11201608761PA (en) 2014-04-23 2015-04-23 Methods of cellular reprogramming

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201401734X 2014-04-23
PCT/SG2015/050082 WO2015163823A1 (en) 2014-04-23 2015-04-23 Methods of cellular reprogramming
SG11201608761PA SG11201608761PA (en) 2014-04-23 2015-04-23 Methods of cellular reprogramming

Publications (1)

Publication Number Publication Date
SG11201608761PA true SG11201608761PA (en) 2016-11-29

Family

ID=54332867

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201608761PA SG11201608761PA (en) 2014-04-23 2015-04-23 Methods of cellular reprogramming

Country Status (4)

Country Link
US (1) US20170121687A1 (en)
CN (1) CN107075466A (en)
SG (1) SG11201608761PA (en)
WO (1) WO2015163823A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180057788A1 (en) 2016-08-29 2018-03-01 EMULATE, Inc. Development of spinal cord on a microfluidic chip
GB2569058B (en) 2016-01-12 2021-04-14 Cedars Sinai Medical Center A method of osteogenic differentiation in microfluidic tissue culture systems
AU2017213795A1 (en) 2016-02-01 2018-08-16 Cedars-Sinai Medical Center Systems and methods for growth of intestinal cells in microfluidic devices
WO2018106536A1 (en) * 2016-12-06 2018-06-14 The Regents Of The University Of California Methods for making and using dedifferentiated and stem-like human cells
WO2018140647A1 (en) 2017-01-25 2018-08-02 Cedars-Sinai Medical Center In vitro induction of mammary-like differentiation from human pluripotent stem cells
US11767513B2 (en) 2017-03-14 2023-09-26 Cedars-Sinai Medical Center Neuromuscular junction
WO2018176001A2 (en) 2017-03-24 2018-09-27 Cedars-Sinai Medical Center Methods and compositions for production of fallopian tube epithelium
US11981918B2 (en) 2018-04-06 2024-05-14 Cedars-Sinai Medical Center Differentiation technique to generate dopaminergic neurons from induced pluripotent stem cells
CN110804582A (en) * 2019-10-29 2020-02-18 广州再生医学与健康广东省实验室 Somatic cell reprogramming method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2461290C (en) * 2001-09-24 2014-11-25 Sangamo Biosciences, Inc. Modulation of stem cells using zinc finger proteins
SE0301087D0 (en) * 2003-04-14 2003-04-14 Cartela Ab New monoclonal antibody
CA2875858C (en) * 2011-06-21 2022-05-03 Georgia Tech Research Corporation Adhesive signature-based methods for the isolation of stem cells and cells derived therefrom

Also Published As

Publication number Publication date
US20170121687A1 (en) 2017-05-04
WO2015163823A1 (en) 2015-10-29
CN107075466A (en) 2017-08-18

Similar Documents

Publication Publication Date Title
HK1231400A1 (en) Selective reduction of proteins
LT3215147T (en) Neuro-attenuating norketamine compounds and methods
IL249607B (en) Tnf-alpha antibodies
IL248280A0 (en) Frequency response
HK1246322A1 (en) Methods of producing long acting ctp-modified polypeptides
GB2527168B (en) Mobility aid
SG11201608761PA (en) Methods of cellular reprogramming
SI3845221T1 (en) Solid state forms of sofosbuvir
GB2522719B (en) Method of manufacture
IL246979A0 (en) Solid state forms of sofosbuvir
HK1243342A1 (en) Compounds and methods
GB2558789B (en) Method of authentication
GB201418395D0 (en) Cyclo-depolymerisation of polybutadiene
GB201416832D0 (en) Methods of treatment
IL252712A0 (en) Method of protein manufacture
GB2522716B (en) Method of manufacture
IL248999A0 (en) Method of geolocation
PL3111151T3 (en) Method of operating an hydraulic-binder rotary-furnace
GB2522904B (en) Method of making an airdam
SG11201607445QA (en) Methods of modulating wars2
IL249332A0 (en) Solid state forms of sofosbuvir
HU4448U (en) Cellular construction-element
GB201420877D0 (en) Radio
AP00717S1 (en) Radio
GB201509143D0 (en) Methods of characterizing polypeptides